EFFECT OF SELECTIVE SEOTONIN REUTAKE INHIBITOR AND COGNITIVE BEHAVIOUR THERAPY COMBINED WITH SELECTIVE SEOTONIN REUTAKE INHIBITOR IN IMPROVING THE EMOTIONAL MATURITY OF CONVERSION DISORDER PATIENTS

Authors

  • Shubhangni iJain Research Scholar, Department of Clinical Psychology, SGT University, Gurugram, Haryana Author
  • Nudrat Jahan Assistant Professor, Department of Clinical Psychology, SGT University, Gurugram, Haryana Author
  • Dinesh Kataria Professor, Department of Psychiatry, Lady Harding Medical College Hospital, New Delhi Author

DOI:

https://doi.org/10.61841/9xxar473

Keywords:

Conversion Disorder, Emotional Maturity, Selective Serotonin Reuptake Inhibitors, Cognitive Behaviour Therapy

Abstract

The aim of this research was to study comparative effectiveness of Selective Serotonin Reuptake Inhibitor (SSRI) alone and Cognitive Behaviour Therapy (CBT) combined with Selective Serotonin Reuptake Inhibitor (SSRI) in improving the emotional maturity of conversion disorder patients. Quasi- experimental research design was is followed for the research. A sample of 30 female patients with conversion disorder was selected. Tool used for this study is Emotional Maturity Scale (EMS) by R.R.Tripathi (1982) was administered on patients suffering from conversion disorder to see the pre-post intervention effect of SSRI alone and CBT+SSRI on emotional maturity. Study revealed that after the 12 weeks of interventions the outcome revealed that the effect of CBT+SSRI intervention was found more successful in improving the emotional maturity of conversion disorder patients.

Downloads

Download data is not yet available.

References

[1] Sadock, V. A. (2007). Synopsis of psychiatry: Behavioral sciences/clinical psychiatry (Trans. H. Rafiei & K. H. Sobhaniyan). Tehran: Arjmand, 2, 135–182.

[2] World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: WHO.

[3] American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychiatric Publishing.

[4] Wenegrat, B. (2001). Theater of disorder: Patients, doctors, and the construction of illness. Oxford: Oxford University Press.

[5] Singh, S. P., & Lee, A. S. (1997). Conversion disorders in Nottingham: Alive, but not kicking. Journal of Psychosomatic Research, 43(4), 425–430.

[6] Deveci, A., Taskin, O., Dinc, G., Yilmaz, H., Demet, M. M., Erbay-Dundar, P., Kaya, E., & Ozmen, E. (2007). Prevalence of pseudoneurologic conversion disorder in an urban community in Manisa, Turkey. Social Psychiatry and Psychiatric Epidemiology, 42(11), 857–864.

[7] Owens, C., & Dein, S. (2006). Conversion disorder: The modern hysteria. Advances in Psychiatric Treatment, 12(2), 152–157.

[8] Grattan-Smith, P., Fairley, M., & Procopis, P. (1988). Clinical features of conversion disorder. Archives of Disease in Childhood, 63(4), 408–414.

[9] Carter, R. B. (1853). On the pathology and treatment of hysteria. London: J. Churchill.

[10] LaFrance, W. C., Jr., & Devinsky, O. (2004). The treatment of nonepileptic seizures: Historical perspectives and future directions. Epilepsia, 45(Suppl. 2), 15–21.

[11] Voon, V., & Lang, A. E. (2005). Antidepressant treatment outcomes of psychogenic movement disorder. Journal of Clinical Psychiatry.

[12] LaFrance, W. C., Jr., & Barry, J. J. (2005). Update on treatments of psychological nonepileptic seizures. Epilepsy & Behavior, 7(3), 364–374.

[13] Faravelli, C., Salvatori, S., Galassi, F., Aiazzi, L., Drei, C., & Cabras, P. (1997). Epidemiology of somatoform disorders: A community survey in Florence. Social Psychiatry and Psychiatric Epidemiology, 32(1), 24–29.

[14] Folks, D. G., Ford, C. V., & Regan, W. M. (1984). Conversion symptoms in a general hospital. Psychosomatics, 25(4), 285–295.

[15] Binzer, M., Andersen, P. M., & Kullgren, G. (1997). Clinical characteristics of patients with motor disability due to conversion disorder: A prospective control group study. Journal of Neurology, Neurosurgery & Psychiatry, 63(1), 83–88.

[16] Kent, D. A., Tomasson, K., & Coryell, W. (1995). Course and outcome of conversion and somatization disorders: A four-year follow-up. Psychosomatics, 36(2), 138–144.

[17] Mace, C. J., & Trimble, M. R. (1996). Ten-year prognosis of conversion disorder. British Journal of Psychiatry, 169(3), 282–288.

[18] Cole, L. (1954). Psychology of adolescence. New York: Rinehart and Company.

[19] Canton, J., Scott, K. M., & Glue, P. (2012). Optimal treatment of social phobia: Systematic review and meta-analysis. Neuropsychiatric Disease and Treatment, 8, 203–215.

[20] Beck, A. T. (1991). Cognitive therapy: A 30-year retrospective. American Psychologist, 46(4), 368–375.

[21] Tripathi, R. R. (1987). The Emotional Maturity Scale: Manual.

[22] Pehlivantürk, B., & Unal, F. (2000). Conversion disorder in children and adolescents: Clinical features and comorbidity with depressive and anxiety disorders. Turkish Journal of Pediatrics, 42(2), 132–137.

[23] Kozlowska, K., Nunn, K. P., Rose, D., Morris, A., Ouvrier, R. A., & Varghese, J. (2007). Conversion disorder in Australian pediatric practice. Journal of the American Academy of Child & Adolescent Psychiatry, 46(1), 68–75.

[24] Jahan, N. D. N. Y. (2019). Cognitive and behavioural coping responses and general health of wives of alcoholics. International Journal of Social Sciences and Review, 7, 60–63.

[25] Khoury, B., & Ammar, J. (2014). Cognitive behavioral therapy for treatment of primary care patients presenting with psychological disorders. Libyan Journal of Medicine, 9, Article 24186.

[26] Vyskocilova, J., Prasko, J., & Sipek, J. (2016). Cognitive behavioral therapy in pharmacoresistant obsessive-compulsive disorder. Neuropsychiatric Disease and Treatment.

[27] Verdurmen, M. J. H., Videler, A. C., Kamperman, A. M., Khasho, D., & van der Feltz-Cornelis, C. M. (2017). Cognitive behavioral therapy for somatic symptom disorders in later life. Neuropsychiatric Disease and Treatment, 13, 2331–2339.

[28] Allin, M., Streeruwitz, A., & Curtis, V. (2005). Progress in understanding conversion disorder. Neuropsychiatric Disease and Treatment, 1(3), 205–209.

[29] Woolfolk, R. L., & Allen, L. A. (2012). Cognitive behavioral therapy for somatoform disorders. In Standard and innovative strategies in cognitive behavior therapy (pp. 117–144). Rijeka, Croatia: InTech.

Downloads

Published

13.07.2020

Issue

Vol. 24 No. 10 (2020): 24 (10) 2020

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

iJain, S., Jahan, N., & Kataria , D. (2020). EFFECT OF SELECTIVE SEOTONIN REUTAKE INHIBITOR AND COGNITIVE BEHAVIOUR THERAPY COMBINED WITH SELECTIVE SEOTONIN REUTAKE INHIBITOR IN IMPROVING THE EMOTIONAL MATURITY OF CONVERSION DISORDER PATIENTS. International Journal of Psychosocial Rehabilitation, 24(10), 3298-3308. https://doi.org/10.61841/9xxar473